JPMorgan Chase & Co. Lowers BioNTech (NASDAQ:BNTX) Price Target to $116.00
BioNTech (NASDAQ:BNTX – Get Free Report) had its target price decreased by research analysts at JPMorgan Chase & Co. from $120.00 to $116.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 17.55% from the […]
BioNTech (NASDAQ:BNTX – Get Free Report) had its target price decreased by research analysts at JPMorgan Chase & Co. from $120.00 to $116.00 in a report issued on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 17.55% from the […]
